Kristoff Rademan
Fortuna: 15 232 $ al 31/05/2026
Fortuna: 15 232 $ al 31/05/2026
Kristoff Rademan currently works at EnSilica Plc, as Chief Financial Officer & Executive Director from 2024.
Mr. Rademan also formerly worked at Oxford Biomedica Plc, as Vice President & Group Financial Controller.
Mr. Rademan received his undergraduate degree from the University of Stellenbosch.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ENSILICA PLC 0,01 % | 31/05/2025 | 10.000 ( 0,01 % ) | 15 232 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ENSILICA PLC | Director Financiero/CFO | 13/05/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Comptroller/Controller/Auditor | 01/05/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
University of Stellenbosch
University of Stellenbosch Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EnSilica Plc
EnSilica Plc SemiconductorsElectronic Technology Designs and develops application-specific integrated circuit & software products | Electronic Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.